Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18042503 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.
Condition: HIV Infections
Interventions: Drug: Viread (tenofovir disoproxil fumarate);   Drug: Sustiva (Efavirenz);   Drug: Epivir (Lamivudine);   Drug: Zerit (Stavudine) Placebo

Indicates status has not been verified in more than two years